PLURY

PLURY is redefining the future of skin health through prejuvenation — the science of prevention before correction. Proudly developed and manufactured in Korea, PLURY delivers advanced skincare and clinical-grade cell therapy solutions backed by exclusive global rights to FECS™ (Functionally Enhanced Cell Spheroid) technology. Our portfolio includes: • s4S SOLUTION — the world’s first clinical prejuvenation product for skin longevity • CFC-FECS-DF — a regenerative skincare ingredient powered by cell secretions • Cell therapy joint ventures — customizable anti-aging treatments using autologous fibroblast spheroids With roots in regenerative medicine and a vision for global wellness, PLURY serves clinics, professionals, and consumers seeking real science behind youthful, resilient skin. We don’t reverse time — we strengthen skin to resist it.